Pinteon Therapeutics is a company that develops cancer therapeutics drugs intended to cure cis-trans isomerase. Its drugs are based out of biotechnological compounds focused on the discovery and development of therapeutics targeting Pin1 and related targets, enabling researchers to normalize aberrant disease processes and improve patient outcomes.